JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Detecting MCI and dementia in primary care: effectiveness of the MMS, the FAQ and the IQCODE [corrected].

Family Practice 2012 August
OBJECTIVES: To study the yield of three instruments for detection of patients with cognitive impairment in primary care. To investigate whether combining tests is better for detecting impairment than applying them separately.

METHODS: Seven primary care physicians (PCP) systematically recruited individuals aged over 49 years with a complaint or suspicion of cognitive impairment. The tests administered were the Mini-Mental State Test (MMS), the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and the Pfeffer Functional Activities Questionnaire (FAQ). We calculated sensitivity, specificity and the area under the curve (AUC) and applied logistic regression analysis to determine the yield of the tests in combination. The gold standard was the clinical judgement of a neurologist based on a comprehensive assessment, which included a formal neuropsychological workup.

RESULTS: Of the 160 study patients, 90 (56%) had cognitive impairment (15 of these had dementia). The MMS had a sensitivity of 77% and a specificity of 70% in screening for cognitive impairment, with an AUC of 0.82. Incorporation of the IQCODE increased the AUC to 0.86 (P = 0.01). As for dementia, the FAQ reached a sensitivity of 87% and a specificity of 82%, with an AUC of 0.91. Incorporation of the MMS increased the AUC to 0.95 (P = 0.03).

CONCLUSIONS: Cognitive impairment is probably underdiagnosed in primary care. The combination of the FAQ and the MMS had excellent performance for dementia detection; however, no satisfactory instrument or instrument combination could be found for cognitive impairment.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app